Crossmark

Pharmacological aspects of FDA-approved novel drug therapies against cancer in 2023: a comprehensive review

Published Online: 2025-03-11

Published Print: 2025-08

Authors

Sangwan, Kavita

Goyal, Parveen Kumar

Sharma, Vipasha
License Information

Text and Data Mining valid from 2025-03-11

Version of Record valid from 2025-03-11
More Information

Article History

Received: 5 February 2025

Accepted: 19 February 2025

First Online: 11 March 2025

Declarations

:

: The authors declare no competing interests.

: Not applicable.

: Not applicable.

: Not applicable.

Document is current